Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients
Background The study investigates the relationship between Plasminogen activator inhibitor-1 (PAI-1) levels and the progression of diabetic nephropathy (DN). The fibrinolytic system is impaired in type 2 diabetes mellitus (DM), leading to elevated PAI-1 levels, increasing the potential for renal fib...
| Үндсэн зохиолчид: | , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Wolters Kluwer Medknow Publications
2023-07-01
|
| Цуврал: | Al-Azhar Assiut Medical Journal |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://journals.lww.com/10.4103/azmj.azmj_22_24 |